Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

Guru Sonpavde; Joaquim Bellmunt; Jonathon E. Rosenberg; Ashley M. Regazzi; Dean F. Bajorin; Toni K. Choueiri; Angela Q. Qu; Guenter Niegisch; Peter Albers; Andrea Necchi; Giuseppe Di Lorenzo; Ronan Fougeray; Yu Ning Wong; Srikala S. Sridhar; Yoo Joung Ko; Matthew I. Milowsky; Matthew D. Galsky; Gregory R. Pond

doi:10.1016/j.clgc.2014.03.016

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

Guru Sonpavde, Joaquim Bellmunt, Jonathon E. Rosenberg, Ashley M. Regazzi, Dean F. Bajorin, Toni K. Choueiri, Angela Q. Qu, Guenter Niegisch, Peter Albers, Andrea Necchi, Giuseppe Di Lorenzo, Ronan Fougeray, Yu Ning Wong, Srikala S. Sridhar, Yoo Joung Ko, Matthew I. Milowsky, Matthew D. Galsky, Gregory R. Pond

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	395-398
Number of pages	4
Journal	Clinical Genitourinary Cancer
Volume	12
Issue number	6
DOIs	https://doi.org/10.1016/j.clgc.2014.03.016
Publication status	Published - 2014

ASJC Scopus subject areas

Oncology
Urology
Medicine(all)

Access to Document

10.1016/j.clgc.2014.03.016

Cite this

Sonpavde, G., Bellmunt, J., Rosenberg, J. E., Regazzi, A. M., Bajorin, D. F., Choueiri, T. K., Qu, A. Q., Niegisch, G., Albers, P., Necchi, A., Di Lorenzo, G., Fougeray, R., Wong, Y. N., Sridhar, S. S., Ko, Y. J., Milowsky, M. I., Galsky, M. D., & Pond, G. R. (2014). Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma. Clinical Genitourinary Cancer, 12(6), 395-398. https://doi.org/10.1016/j.clgc.2014.03.016

Sonpavde, G, Bellmunt, J, Rosenberg, JE, Regazzi, AM, Bajorin, DF, Choueiri, TK, Qu, AQ, Niegisch, G, Albers, P, Necchi, A, Di Lorenzo, G, Fougeray, R, Wong, YN, Sridhar, SS, Ko, YJ, Milowsky, MI, Galsky, MD & Pond, GR 2014, 'Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma', Clinical Genitourinary Cancer, vol. 12, no. 6, pp. 395-398. https://doi.org/10.1016/j.clgc.2014.03.016

@article{c319eb25204d497ca2fd6c058579c768,

title = "Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma",

author = "Guru Sonpavde and Joaquim Bellmunt and Rosenberg, {Jonathon E.} and Regazzi, {Ashley M.} and Bajorin, {Dean F.} and Choueiri, {Toni K.} and Qu, {Angela Q.} and Guenter Niegisch and Peter Albers and Andrea Necchi and {Di Lorenzo}, Giuseppe and Ronan Fougeray and Wong, {Yu Ning} and Sridhar, {Srikala S.} and Ko, {Yoo Joung} and Milowsky, {Matthew I.} and Galsky, {Matthew D.} and Pond, {Gregory R.}",

year = "2014",

doi = "10.1016/j.clgc.2014.03.016",

language = "English",

volume = "12",

pages = "395--398",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

AU - Sonpavde, Guru

AU - Bellmunt, Joaquim

AU - Rosenberg, Jonathon E.

AU - Regazzi, Ashley M.

AU - Bajorin, Dean F.

AU - Choueiri, Toni K.

AU - Qu, Angela Q.

AU - Niegisch, Guenter

AU - Albers, Peter

AU - Necchi, Andrea

AU - Di Lorenzo, Giuseppe

AU - Fougeray, Ronan

AU - Wong, Yu Ning

AU - Sridhar, Srikala S.

AU - Ko, Yoo Joung

AU - Milowsky, Matthew I.

AU - Galsky, Matthew D.

AU - Pond, Gregory R.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84922729773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922729773&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2014.03.016

DO - 10.1016/j.clgc.2014.03.016

M3 - Article

C2 - 25035282

AN - SCOPUS:84922729773

SN - 1558-7673

VL - 12

SP - 395

EP - 398

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 6

ER -

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this